Monday, April 20, 2026

CMS published a proposed rule on April 14, 2026, aiming to streamline prior authorization processes and advance interoperability for drugs covered by Medicare Advantage, Medicaid managed care, CHIP, and QHP plans. The rule targets standards for electronic PA requests and responses, requiring payers to implement specific APIs and adhere to standardized timelines. For practices, this signals a potential reduction in manual fax and phone-based PA workflows for medications, but the changes are not immediate. The comment period is open, with a final rule and implementation timeline expected later in 2026. Monitor CMS-2026-07205 for the final rule, which will dictate new submission requirements.

CMS and the FDA announced the new RAPID Coverage Pathway, a coordinated effort to accelerate Medicare coverage for FDA-designated breakthrough medical devices. The program aims to reduce the typical multi-year gap between FDA approval and Medicare coverage determination. For practices, this means patient access to novel technologies (like certain AI diagnostics, gene therapies, or advanced implants) could be faster, potentially reducing coverage denial rates for these items. However, billing teams will need to verify a device's RAPID status and any associated National Coverage Determination (NCD) or Local Coverage Determination (LCD) requirements before submission, as specific coding and documentation rules will apply.

UnitedHealthcare is expanding its rural health financial stability program, which eliminates most prior authorization requirements for providers in designated rural areas. This policy shift, effective upon program enrollment, applies to both Medicare Advantage and commercial plans. For eligible rural practices, this means a significant reduction in administrative burden for services like outpatient imaging, specialist visits, and many inpatient admissions. Rural clinics should immediately check their eligibility via the UHC provider portal and enroll to activate the PA relief. Confirm which service categories are included to adjust your front-office workflow and reduce PA-related staff time.

CMS and the FDA jointly announced the RAPID Coverage Pathway, a new program designed to accelerate Medicare coverage for FDA-designated breakthrough medical devices. The pathway establishes parallel review and creates predictable, expedited national coverage determinations. The first devices are expected to enter the program in early 2027. For practices, this signals faster patient access to novel technologies like advanced cardiac monitors or AI-based diagnostics, but also introduces new coding and billing considerations as these devices transition from FDA approval to Medicare payment. The policy is a structural shift aimed at closing the gap between device approval and reimbursement.